- Home
- DNTH vs AZTA Comparison
DNTH vs AZTA Comparison
Compare DNTH & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- AZTA
- Stock Information
- Founded
- DNTH 2015
- AZTA 1978
- Country
- DNTH United States
- AZTA United States
- Employees
- DNTH N/A
- AZTA N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- AZTA Industrial Machinery/Components
- Sector
- DNTH Health Care
- AZTA Technology
- Exchange
- DNTH Nasdaq
- AZTA Nasdaq
- Market Cap
- DNTH 1.5B
- AZTA 1.4B
- IPO Year
- DNTH N/A
- AZTA 1995
- Fundamental
- Price
- DNTH $34.50
- AZTA $30.83
- Analyst Decision
- DNTH Strong Buy
- AZTA Buy
- Analyst Count
- DNTH 10
- AZTA 4
- Target Price
- DNTH $66.38
- AZTA $42.00
- AVG Volume (30 Days)
- DNTH 947.1K
- AZTA 654.4K
- Earning Date
- DNTH 11-06-2025
- AZTA 11-11-2025
- Dividend Yield
- DNTH N/A
- AZTA N/A
- EPS Growth
- DNTH N/A
- AZTA N/A
- EPS
- DNTH N/A
- AZTA N/A
- Revenue
- DNTH $4,854,000.00
- AZTA $668,821,000.00
- Revenue This Year
- DNTH N/A
- AZTA N/A
- Revenue Next Year
- DNTH N/A
- AZTA $4.18
- P/E Ratio
- DNTH N/A
- AZTA N/A
- Revenue Growth
- DNTH 17.87
- AZTA 12.46
- 52 Week Low
- DNTH $13.37
- AZTA $23.91
- 52 Week High
- DNTH $40.16
- AZTA $55.64
- Technical
- Relative Strength Index (RSI)
- DNTH 50.57
- AZTA 52.46
- Support Level
- DNTH $33.96
- AZTA $27.80
- Resistance Level
- DNTH $40.16
- AZTA $33.09
- Average True Range (ATR)
- DNTH 2.12
- AZTA 1.18
- MACD
- DNTH -0.97
- AZTA 0.24
- Stochastic Oscillator
- DNTH 4.03
- AZTA 59.45
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.